NFA
NVIV

Nationwide Fund Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Nationwide Fund Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$81K – 3313
2017
Q1 		$81K Hold
1
– – ﹤0.01% 2898
2016
Q4 		$84K Hold
1
– – ﹤0.01% 2921
2016
Q3 		$157K Hold
1
– – ﹤0.01% 2740
2016
Q2 		$134K Hold
1
– – ﹤0.01% 2802
2016
Q1 		$143K Hold
1
– – ﹤0.01% 2687
2015
Q4 		$123K Hold
1
– – ﹤0.01% 2766
2015
Q3 		$147K Hold
1
– – ﹤0.01% 2726
2015
Q2 		$276K Buy
+1
New +$264K ﹤0.01% 2546

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's NVIV Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 1 share — an estimated $81K sold.

Nationwide Fund Advisors first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $276K in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1 InVivo Therapeutics Holdings Corp share in Q2 2017, an estimated $81K.
  • Nationwide Fund Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's InVivo Therapeutics Holdings Corp position peaked at $276K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.